291 related articles for article (PubMed ID: 9815903)
1. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis.
Givehchian M; Woerner SM; Lacroix J; Zöller M; Drings P; Becker H; Kayser K; Ridder R; von Knebel Doeberitz M
Oncogene; 1996 Mar; 12(5):1137-44. PubMed ID: 8649806
[TBL] [Abstract][Full Text] [Related]
3. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.
Dall P; Heider KH; Hekele A; von Minckwitz G; Kaufmann M; Ponta H; Herrlich P
Cancer Res; 1994 Jul; 54(13):3337-41. PubMed ID: 7516819
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
[TBL] [Abstract][Full Text] [Related]
5. Splice variants of CD44 in human cervical cancer stage IB to IIB.
Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD44 variant isoforms in malignant melanoma.
Seiter S; Schadendorf D; Herrmann K; Schneider M; Rösel M; Arch R; Tilgen W; Zöller M
Clin Cancer Res; 1996 Mar; 2(3):447-56. PubMed ID: 9816190
[TBL] [Abstract][Full Text] [Related]
7. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
Ermak G; Jennings T; Robinson L; Ross JS; Figge J
Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression.
Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K
Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431
[TBL] [Abstract][Full Text] [Related]
9. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations.
Weber B; Rösel M; Arch R; Möller P; Zöller M
Differentiation; 1996 Mar; 60(1):17-29. PubMed ID: 8935925
[TBL] [Abstract][Full Text] [Related]
10. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells.
Soukka T; Salmi M; Joensuu H; Häkkinen L; Sointu P; Koulu L; Kalimo K; Klemi P; Grénman R; Jalkanen S
Cancer Res; 1997 Jun; 57(11):2281-9. PubMed ID: 9187133
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R
Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637
[TBL] [Abstract][Full Text] [Related]
12. CD44 splice variants: expression during lymphocyte activation and tumor progression.
Pals ST; Koopman G; Heider KH; Griffioen A; Adolf GR; Van den Berg F; Ponta H; Herrlich P; Horst E
Behring Inst Mitt; 1993 Aug; (92):273-7. PubMed ID: 7504454
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells.
Liu NP; Roberts WL; Hale LP; Levesque MC; Patel DD; Lu CL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2027-37. PubMed ID: 9331266
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer.
Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G
Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
Fichtner I; Dehmel A; Naundorf H; Finke LH
Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
[TBL] [Abstract][Full Text] [Related]
16. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
Godge PY; Poonja LS
Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of CD44 expression in invasive squamous cell carcinoma of the vulva.
Rodríguez-Rodríguez L; Sancho-Torres I; Miller Watelet L; Gibbon DG; Comerci JT; Mesonero C
Gynecol Oncol; 1999 Oct; 75(1):34-40. PubMed ID: 10502422
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CD44 variants 6 and 7 in human endometrial cancer.
Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T
Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458
[TBL] [Abstract][Full Text] [Related]
20. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
Kryworuckho M; Diaz-Mitoma F; Kumar A
Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]